The Use of Aromatherapy for Symptom Management

February 3, 2015 updated by: Central DuPage Hospital

The purpose of this pilot study is to introduce the use of aromatherapy/essential oils to medical oncology patients at Central DuPage Hospital to assess their perceived effectiveness to relieve symptoms of nausea or vomiting and/or anxiety.

Peppermint oil will be used for nausea/vomiting and lavender oil will be used for anxiety. This study will involve administration of aromatherapy to a convenience sample of patients, who will then be asked to complete a brief questionnaire. The questionnaire will involve a simple likert scale to measure efficacy (in the opinion of the patient) and simple multiple-choice questions to determine patients' likeliness to use aromatherapy again.

Study Overview

Status

Unknown

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Anticipated)

40

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

  • United States
    • Illinois
      • Winfield, Illinois, United States, 60190
        • Recruiting
        • Central DuPage Hospital
        • Contact:
          • Mary Lyons, MSN, APN/CNS, RN-BC ONC
          • Phone Number: 630-933-6011
        • Contact:
          • Lorraine Mack, RN
          • Phone Number: 630-933-3413

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Adult hospitalized medical oncology patients admitted to Central DuPage Hospital.
  • Age 18 years or greater.
  • Able to understand and speak English.
  • Women of non-childbearing potential or with childbearing potential with a negative pregnancy test documented during the hospital stay.
  • Able to understand concept of aromatherapy for treatment of distressing symptoms.

Exclusion Criteria:

  • Prisoners.
  • Non-English speaking patients.
  • Under the age of 18.
  • Unable to comprehend the concept of aromatherapy.
  • Severe cognitive impairment.
  • Not experiencing the symptoms of nausea, vomiting or anxiety.
  • Women with child-bearing potential who have not had a negative pregnancy test during the hospital stay.
  • Patients with known allergy to lavender or peppermint.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Peppermint and Lavender Essential Oils
Drug: Peppermint and Lavender Essential Oils

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Post Intervention Patient Interview Form
Time Frame: 24hrs post aromatherapy
24hrs post aromatherapy

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Central DuPage Hospital

Investigators

  • Principal Investigator: Mary Lyons, MSN, APN/CNS, RN-BC, ONC, Central DuPage Hospital

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

July 1, 2014

Primary Completion (Anticipated)

June 1, 2015

Study Registration Dates

First Submitted

June 11, 2014

First Submitted That Met QC Criteria

June 12, 2014

First Posted (Estimate)

June 13, 2014

Study Record Updates

Last Update Posted (Estimate)

February 4, 2015

Last Update Submitted That Met QC Criteria

February 3, 2015

Last Verified

February 1, 2015

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 14-031-1

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Nausea, Vomiting and Anxiety Associated With Medical Oncology Patients

Clinical Trials on Peppermint and Lavender Essential Oils

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Saudi Arabia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe